Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Buy
73
GLAD Quote, Financials, Valuation and Earnings
Last price:
$27.84
Seasonality move
:
0.35%
Day range:
$27.05 - $27.81
52-week range:
$19.20 - $28.40
Dividend yield:
7.14%
P/E ratio:
4.38x
P/S ratio:
4.60x
P/B ratio:
1.32x
Volume:
108.6K
Avg. volume:
141.4K
1-year change:
31.55%
Market cap:
$619.2M
Revenue:
$98.5M
EPS (TTM):
$6.34
Analysts' Opinion
-
Consensus RatingGladstone Capital has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 4 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Gladstone Capital has an estimated downside of -12.1% from its current price of $27.73.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $27.73.
Fair Value
-
According to the consensus of 5 analysts, Gladstone Capital has -12.1% downside to fair value with a price target of -- per share.
GLAD vs. S&P 500
-
Over the past 5 trading days, Gladstone Capital has underperformed the S&P 500 by -0.14% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Gladstone Capital does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Gladstone Capital has grown year-over-year revenues for 5 quarters straight. In the most recent quarter Gladstone Capital reported revenues of $33.1M.
Earnings Growth
-
Gladstone Capital has grown year-over-year earnings for 5 quarters straight. In the most recent quarter Gladstone Capital reported earnings per share of $1.46.
Enterprise value:
949.5M
EV / Invested capital:
1.18x
Price / LTM sales:
4.60x
EV / EBIT:
8.15x
EV / Revenue:
9.63x
PEG ratio (5yr expected):
0.04x
EV / Free cash flow:
293.05x
Price / Operating cash flow:
139.87x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
12.19%
Net Income Margin (TTM):
96.12%
Return On Equity:
21.7%
Return On Invested Capital:
12.34%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $20.1M | $45M | $98.5M | $14.2M | $33.1M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $1.16 | $2.94 | $6.34 | $0.67 | $1.46 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $7.5M | $6M | $7.9M | $10.3M | $10.9M | |
| Total Assets | $459.2M | $566.5M | $661M | $719.5M | $812.5M | |
| Current Liabilities | $3.6M | $4.9M | $5.5M | $8.3M | $8.6M | |
| Total Liabilities | $225.4M | $248.1M | $345.5M | $310.8M | $333.7M | |
| Total Equity | $233.7M | $318.4M | $315.5M | $408.7M | $478.7M | |
| Total Debt | $221.5M | $237.1M | $339.4M | $300.9M | $324.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$76.4M | -$10.9M | $3.2M | $22.9M | -$5.7M | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | $77.7M | $10.2M | -$2.3M | -$23.3M | $6.8M | |
| Free Cash Flow | -$76.4M | -$10.9M | $3.2M | $22.9M | -$5.7M | |
GLAD
Sector
Market Cap
$619.2M
$694.8M
Price % of 52-Week High
97.64%
87.67%
Dividend Yield
7.14%
2.22%
Shareholder Yield
7.56%
3.87%
1-Year Price Total Return
31.55%
7.29%
Beta (5-Year)
1.279
0.737
Dividend yield:
7.14%
Annualized payout:
$1.98
Payout ratio:
45.55%
Growth streak:
3 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$27.61
200-day SMA
Buy
Level
$23.37
Bollinger Bands (100)
Buy
Level
22.8 - 26.36
Chaikin Money Flow
Sell
Level
-15.7M
20-day SMA
Buy
Level
$27.45
Relative Strength Index (RSI14)
Buy
Level
59.56
ADX Line
Sell
Level
3.47
Williams %R
Neutral
Level
-32.0574
50-day SMA
Buy
Level
$26.01
MACD (12, 26)
Buy
Level
0.45
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Neutral
Level
392.7K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.5835)
Buy
CA Score
(Annual)
Level (0.6339)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-0.8292)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.
Stock Forecast FAQ
In the current month, GLAD has received 1 Buy ratings 4 Hold ratings, and 0 Sell ratings. The GLAD average analyst price target in the past 3 months is --.
-
Where Will Gladstone Capital Stock Be In 1 Year?
According to analysts, the consensus estimate is that Gladstone Capital share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Gladstone Capital?
Analysts are divided on their view about Gladstone Capital share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Gladstone Capital is a Sell and believe this share price will rise from its current level to --.
-
What Is Gladstone Capital's Price Target?
The price target for Gladstone Capital over the next 1-year time period is forecast to be -- according to 5 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is GLAD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Gladstone Capital is a Hold. 4 of 5 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of GLAD?
You can purchase shares of Gladstone Capital via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Gladstone Capital shares.
-
What Is The Gladstone Capital Share Price Today?
Gladstone Capital was last trading at $27.84 per share. This represents the most recent stock quote for Gladstone Capital. Yesterday, Gladstone Capital closed at $27.73 per share.
-
How To Buy Gladstone Capital Stock Online?
In order to purchase Gladstone Capital stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
73
PSIX alert for Dec 24
Power Solutions International [PSIX] is up 27.42% over the past day.
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 8.07% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is down 1.39% over the past day.
